ARCHIVES

NCI relaxes Core Grants Support For Clinical Trials Research

This article is from The Cancer Letter archive.

Vol. 18 No. 48 | December 11, 1992

Download PDF Visit The Full Archive

Related Articles

Research Advocates Prepare to Face Republican-led Congress

December 19, 2014

In Brief: AACR, ASCO Meeting In Toronto; Regional Planners Threaten Cancer Program Delays

April 9, 1976

White House To Appoint Richard Klausner, Molecular Biologist, As NCI’s 11th Director

July 28, 1995

Troubles of Two Landmark Cancer Drugs, Celebrex and Iressa, Likely to Shape cancer Prevention, FDA Policy. FDA Mulls Withdrawal of Iressa.

January 7, 2005

List of FY97 SPORE Grantees and Their Awards

December 12, 1997

An Earmark For Pancreatic Cancer

August 3, 2012